Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 32 clinical trials
Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB)

OCTOCAB is a prospective, randomized (1:1), single-center trial. The purpose of this study is to determine whether intravascular optical coherence tomography (OCT) guided saphenous vein grafting in coronary artery bypass surgery will reduce the rate of early vein graft failure (VGF).

  • 0 views
  • 13 May, 2022
  • 1 location
Total Arterial Revascularization (TAR)

Total arterial revascularisation with in-situ confihuration of BITA is superior than y-graft in patients underwent CABG.

revascularisation
bypass graft
atherosclerosis
arterial disease
stable angina
  • 14 views
  • 01 Feb, 2022
  • 1 location
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.

Due to the lack of randomized controlled trials, the best follow-up strategy of asymptomatic patients after coronary artery revascularization is controversial. A systematic screening of silent myocardial ischemia may help prevent a major acute cardiac event. However, systematic screening strategy is costly and there is currently no evidence that repeated …

revascularisation
cardiac event
ischemia
coronary revascularization
exercise stress test
  • 0 views
  • 28 Nov, 2021
  • 1 location
Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery (NEWTON-CABG)

The purpose of this study is to determine if evolocumab added to regular statin therapy improves vein graft patency after coronary artery bypass graft (CABG) surgery.

rosuvastatin
niacin
atorvastatin
cardiovascular disease
simvastatin
  • 28 views
  • 09 Feb, 2022
  • 9 locations
The TransCatheter Valve and Vessels Trial (TCW)

The trial objective is to investigate whether Fractional Flow Reserve (FFR)-Guided Percutaneous Coronary Intervention (PCI) and TransCatheter Aortic Valve Implantation (TAVI) strategy for treatment of multivessel disease and aortic stenosis will be non-inferior to Coronary Artery By-pass Grafting (CABG) and Surgical Aortic Valve Replacement (SAVR) for a composite primary endpoint …

stroke
transcatheter aortic valve implantation
aortic valve replacement
coronary artery bypass graft
infarct
  • 55 views
  • 20 Jul, 2022
  • 20 locations
Comparison of Postoperative Analgesic Efficacy of Combine Serratus Anterior Plane Block and Erector Spinae Plane Block in Coronary Bypass Surgery: Randomized Controlled Study

effect for sternotomy and drain tube pain relief. This study aims to compare ESP block and CSAP block for postoperative analgesia in coronary bypass surgery patients.

bupivacaine
bypass surgery
bypass graft
pain relief
analgesia
  • 0 views
  • 19 Aug, 2022
  • 1 location
TELEsurveillance of Patients in PostopErative Bridge surgeryAge CoronairE (TELE-PEACE)

More than 20,000 patients benefit from coronary bypass surgery in France each year. Median discharge without complication is eight days postoperatively, whereas by day four after surgery

  • 0 views
  • 12 Apr, 2022
  • 1 location
Computed Tomography Coronary Angiography in Patients With a Previous Coronary Artery Bypass Graft Surgery Trial (GREECE)

This randomized, multi-center, prospective study seeks to compare the conventional invasive Coronary Angiography with the recently described method of performing CT-Coronary Angiography prior to the invasive Coronary Angiography, in post - CABG patients subjected to coronary angiography or percutaneous coronary intervention.

  • 0 views
  • 28 Apr, 2022
  • 1 location
Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

To determine the effects of scapular mobilization on pulmonary functions of post-CABG patients.

  • 0 views
  • 09 May, 2022
  • 1 location
Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting

Acute kidney injury is a frequent complication after coronary artery bypass grafting (CABG). Roxadustat is a prolyl hydroxylase inhibitor (PHI) which can stabilize hypoxia-inducible factor (HIF) and improve the hypoxic tolerance of tissues. Roxadustat has shown effect in reducing acute kidney injury in animal studies. This study aims to evaluate …

  • 0 views
  • 01 May, 2022
  • 1 location